Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04744038 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of PAP Therapy for Treating OSA in the Home Environment
A NA study, sponsored by ResMed.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT04744038 is a NA study that has completed, run by ResMed. The registered enrollment target is 108 participants.
The verdict
NCT04744038, a NA study, has completed, sponsored by ResMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
This study will take between 4-6 months (with first patient first visit to last patient last visit expected to span 3-4 months across all study sites). Each participant will use the investigational PAP device with their own mask for a period of up to 7 nights and will complete a series of questionnaires upon completion. The study will evaluate the usability and efficacy of the investigational device in the intended use environment by the intended use population.
Interventions
- DEVICE Positive Airway Pressure (PAP) Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2020-08-12 |
| Est. Completion | 2021-03-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04744038
The ClinicalTrials.gov registry entry for NCT04744038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ResMed, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Positive Airway Pressure (PAP) Therapy is the first listed.
NCT04744038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04744038 about?
NCT04744038 is a clinical study titled "Evaluating the Efficacy of PAP Therapy for Treating OSA in the Home Environment". This study will take between 4-6 months (with first patient first visit to last patient last visit expected to span 3-4 months across all study sites). Each participant will use the investigational PAP device with their own mask for a period of up to 7 nights and will complete a series of questionna...
What is the current status of trial NCT04744038?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2020-08-12. Estimated completion is 2021-03-05.
What interventions are being tested in trial NCT04744038?
The interventions under investigation include: Positive Airway Pressure (PAP) Therapy (DEVICE).
Who is sponsoring clinical trial NCT04744038?
This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.